Brand-name vs compounded
Hers vs Novi: Brand-Name or Compounded? (2026)
Hers $149/mo vs Novi $133/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Comparing Hers with Novi means comparing two business models more than two medications. The molecules overlap; the terms do not.
The dividing line is regulatory, not cosmetic: Hers works with product the FDA has reviewed and approved, while Novi runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
Everything here is drawn from each provider's own published pricing and program detail, then extended into six- and twelve-month totals so the two become comparable. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Novi — $1,596 against $1,788 at Hers, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Longest public track record
- Novi — 50,124 patient reviews against 6,200.
Hers and Novi, side by side
Read the second row before the first: the advertised price and the price you actually run at are frequently different numbers.
| Hers | Novi | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | $149/mo | $133/mo |
| Pricing structure | Published rate per medication | Published rate per medication |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | $166/mo |
| Price transparency | Published upfront | Published upfront |
| Shipping | Home delivery, no insurance required | Free 2-day shipping with every order |
| Support model | Provider check-ins included | No coaching program stated |
| Patient reviews | 6,200 | 50,124 |
| eRxDoctor score | 9.8/10 | 7.0/10 |
What you will have spent by month twelve
Almost every complaint about telehealth GLP-1 pricing traces back to comparing month one instead of month twelve. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Hers | Novi | |
|---|---|---|
| First month | $149 | $133 |
| Months 2 onward | $149/mo | $133/mo |
| 6-month total | $894 | $798 |
| 12-month total | $1,788 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Novi finishes the year $192 cheaper. For some patients the support Hers bundles closes that gap; for a patient who only needs the prescription written, it does not.
Brand-name product versus a pharmacy preparation
On Hers's side of the line sits FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — product manufactured under an approved application, with the batch-to-batch consistency that approval requires.
Novi works with compounded semaglutide and compounded tirzepatide. Compounding is what puts $133/mo within reach; it also means no approval application stands behind the specific product you receive.
Neither choice is wrong, but they are different risks. Paying $149/mo buys regulatory certainty. Paying less buys access, on terms where the manufacturing oversight is not the same.
Hers in detail
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications. Against Novi, that puts it in the position of the more expensive option.
The process is online intake with clinician review, then home delivery, no insurance required. On money, expect published rate per medication — published upfront.
Behind the prescription sits personalized care team with ongoing dose check-ins. Available medication: FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- No insurance required
- Personalized care team with ongoing dose check-ins
- FDA-approved brand-name Wegovy®, not a compounded product
Hers cons
- Higher starting price than most compounded competitors
- No compounded/generic alternative offered
The cost of choosing this over Novi: there is no compounded tier to fall back on if the brand-name price stops working for you.
A closer look at Novi
Novi positions itself on the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. $200 OFF - GLP-1 for $133 Today
You start with online intake; medication arrives via free 2-day shipping with every order. The price behaves as published rate per medication.
Ongoing care is no long-term contract, cancel anytime, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Novi pros
- No insurance required and no long-term contract, cancel anytime
- $200 off promotion brings GLP-1 to $133 today
- Free 2-day shipping included with every order
- Both compounded semaglutide and tirzepatide available
Novi cons
- No published outcome or weight loss guarantee
- Tirzepatide ($166) costs more than the semaglutide entry rate
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
The reservation worth holding, particularly next to Hers: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Who each program is actually built for
Choose Hers if:
- delivery works the way you want it to: home delivery, no insurance required
- the feature you would actually use: brand-name Wegovy at a price that usually buys compounded medication elsewhere
- you want an FDA-approved finished medication rather than a compounded preparation
- you want to start on their timeline: online intake with clinician review
Choose Novi if:
- delivery works the way you want it to: free 2-day shipping with every order
- you want to start on their timeline: online intake
- the level of clinical contact suits you: no long-term contract, cancel anytime
- you would get real value from the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
What each one gives up
On price. $133/mo against $149/mo. Hers is asking you to pay for brand-name Wegovy at a price that usually buys compounded medication elsewhere; decide whether that is a line item you will use.
On medication. Hers covers FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen; Novi covers compounded semaglutide and compounded tirzepatide. Only Novi publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. The support models differ — personalized care team with ongoing dose check-ins against no long-term contract, cancel anytime — and that difference is felt in week two, not week one.
On predictability. Published rate per medication versus published rate per medication. Whichever you pick, get the maintenance-dose price in writing at intake.
The medication, not the platform
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
Hers vs Novi: common questions
Which is cheaper to start, Hers or Novi?
Novi, at $133 against $149. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, Hers or Novi?
Novi, at roughly $1,596 for twelve months against $1,788 at Hers, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Novi cheaper than Hers?
Yes, on the ongoing rate. Novi runs $133/mo once promotional pricing ends, against $149/mo at Hers — a difference of 12%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
How fast can I start with Hers compared with Novi?
Hers advertises online intake with clinician review, with home delivery, no insurance required. Novi advertises online intake, with free 2-day shipping with every order. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Does Hers or Novi offer tirzepatide?
Novi does, at $166/mo. Hers publishes FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Hers and Novi prescribe the same medication?
No. Hers dispenses brand-name, FDA-approved finished medication; Novi dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
Are Hers and Novi legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Hers operates on published rate per medication with pricing published upfront, Novi on published rate per medication, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Novi is the cheaper year by $192, and for a straightforward course of treatment that settles it.
The case for Hers is brand-name Wegovy at a price that usually buys compounded medication elsewhere. That is worth $16 a month to some patients and nothing at all to others — be honest about which you are.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Hers vs RefillsBrand-name vs compounded
- Hers vs EmbodyBrand-name vs compounded
- Enhance MD vs NoviBudget vs premium
- altRx vs NoviBudget vs premium
- Ro.co vs Elevate HealthBrand-name vs compounded
- Ro.co vs TMatesBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or Novi, and does not sell treatment. Read our ranking methodology.